Upregulation and expression patterns of the angiogenic transcription factor Ets-1 in Alzheimer's disease brain

Journal of Alzheimer's Disease

Volumn 37, Issue 2, 2013, Pages 367-377

  Jantaratnotai, Nattinee ^a   Ling, Alden ^b   Cheng, Jenny ^b   Schwab, Claudia ^b   Mcgeer, Patrick L ^b   Mclarnon, James G ^b  

^a MAHIDOL UNIVERSITY   (Thailand)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease; amyloid ; angiogenesis; Ets 1; microglia; tumor necrosis factor (TNF ); vascular endothelial growth factor (VEGF)

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-40]; TRANSCRIPTION FACTOR ETS 1; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

AGED; ALZHEIMER DISEASE; AMYLOID PLAQUE; ANGIOGENESIS; ARTICLE; BRAIN TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; EXTRAVASCULAR SPACE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENILE PLAQUE; UPREGULATION;

AGE FACTORS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANALYSIS OF VARIANCE; CREUTZFELDT-JAKOB SYNDROME; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUOROMETRY; FRONTOTEMPORAL DEMENTIA; HUMANS; LINEAR MODELS; MALE; MIDDLE AGED; NEPRILYSIN; PROTO-ONCOGENE PROTEIN C-ETS-1; TAU PROTEINS; UP-REGULATION;

EID: 84883760500     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122191     Document Type: Article

References (40)

1. Akiyama H, Barger S, Barnum S, Bradt B, Bauer J, Cole GM, Cooper NR, Eikelenboom P, Emmerling M, Fiebich BL, Finch CE, Frautschy S, Griffin WS, Hampel H, Hull M, Landreth G, Lue L, Mrak R, Mackenzie IR, McGeer PL, O'Banion MK, Pachter J, Pasinetti G, Plata-Salaman C, Rogers J, Rydel R, Shen Y, StreitW, Strohmeyer R, Tooyoma I, VanMuiswinkel FL,Veerhuis R,Walker D,Webster S,Wegrzyniak B,Wenk G, Wyss-Coray T (2000) Inflammation and Alzheimer's disease. Neurobiol Aging 21, 383-421.
2. McGeer EG, McGeer PL (2003) Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 27, 741-749.
3. Querfurth HW, LaFerla FM (2010) Alzheimer's disease. N Engl J Med 362, 329-344.
4. Zlokovic BV (2008) The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178-201.
5. de laTorre JC (2002) Alzheimer disease as a vascular disorder: Nosological evidence. Stroke 33, 1152-1162.
6. Miyakawa T, Uehara Y, Desaki J, Kimura T, Kuramoto R (1988) Morphological changes of microvessels in the brain with Alzheimer's disease. Jpn J Psychiatry Neurol 42, 819- 824.
7. Cullen KM, Kocsi Z, Stone J (2006) Microvascular pathology in the aging human brain: Evidence that senile plaques are sites of microhaemorrhages. Neurobiol Aging 27, 1786-1796.
8. Zipser BD, Johanson CE, Gonzalez L, Berzin TM, Tavares R, Hulette CM, Vitek MP, Hovanesian V, Stopa EG (2007) Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol Aging 28, 977-986.
9. Biron KE, Dickstein DL, Gopaul R, Jefferies WA (2011) Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease. PLoS One 6, e23789.
10. Jantaratnotai N, Ryu JK, Schwab C, McGeer PL, McLarnon JG (2011) Comparison of vascular perturbations in an Abetainjected animal model and in AD brain. Int J Alzheimers Dis 2011, 918280.
11. Jantaratnotai N, Schwab C, Ryu JK, McGeer PL, McLarnon JG (2010) Converging perturbed microvasculature and microglial clusters characterize Alzheimer disease brain. Curr Alzheimer Res 7, 625-636.
12. Desai BS, Schneider JA, Li JL, Carvey PM, Hendey B (2009) Evidence of angiogenic vessels in Alzheimer's disease. J Neural Transm 116, 587-597.
13. Zand L, Ryu JK, McLarnon JG (2005) Induction of angiogenesis in the beta-amyloid peptide-injected rat hippocampus. Neuroreport 16, 129-132.
14. Paris D, Patel N, DelleDonne A, Quadros A, Smeed R, Mullan M(2004) Impaired angiogenesis in a transgenic mouse model of cerebral amyloidosis. Neurosci Lett 366, 80-85.
15. de la Torre JC (2000) Cerebral hypoperfusion, capillary degeneration, and development of Alzheimer disease. Alzheimer Dis Assoc Disord 14(Suppl 1), S72-S81.
16. Vagnucci AH, Jr, Li WW (2003) Alzheimer's disease and angiogenesis. Lancet 361, 605-608.
17. Kalaria RN, Cohen DL, Premkumar DR, Nag S, LaManna JC, Lust WD (1998) Vascular endothelial growth factor in Alzheimer's disease and experimental cerebral ischemia. Brain Res Mol Brain Res 62, 101-105.
18. Grammas P,OvaseR(2001) Inflammatory factors are elevated in brain microvessels in Alzheimer's disease. Neurobiol Aging 22, 837-842.
19. Grammas P (2011) Neurovascular dysfunction, inflammation and endothelial activation: Implications for the pathogenesis of Alzheimer's disease. J Neuroinflammation 8, 26.
20. Pogue AI, Lukiw WJ (2004) Angiogenic signaling in Alzheimer's disease. Neuroreport 15, 1507-1510.
21. Ryu JK, Little JP, Klegeris A, Jantaratnotai N, McLarnon JG (2013) Actions of the anti-angiogenic compound angiostatin in an animal model of Alzheimer's disease. Curr Alzeimer Res 10, 252-260.
22. Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG (2009) MicroglialVEGFreceptor response is an integral chemotactic component in Alzheimer's disease pathology. J Neurosci 29, 3-13.
23. Sunderkotter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C (1994) Macrophages and angiogenesis. J Leukoc Biol 55, 410-422.
24. Ryu JK, McLarnon JG (2008) Thalidomide inhibition of perturbed vasculature and glial-derived tumor necrosis factoralpha in an animal model of inflamed Alzheimer's disease brain. Neurobiol Dis 29, 254-266.
25. Lue LF, Walker DG, Rogers J (2001) Modeling microglial activation in Alzheimer's disease with human postmortem microglial cultures. Neurobiol Aging 22, 945-956.
26. Dittmer J (2003) The biology of the Ets1 proto-oncogene. Mol Cancer 2, 29.
27. Valter MM, Hugel A, Huang HJ, Cavenee WK,Wiestler OD, Pietsch T,WernertN(1999) Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis. Cancer Res 59, 5608-5614.
28. Oettgen P (2010) The role of ets factors in tumor angiogenesis. J Oncol 2010, 767384.
29. Oda N, Abe M, Sato Y (1999) ETS-1 converts endothelial cells to the angiogenic phenotype by inducing the expression of matrix metalloproteinases and integrin beta3. J Cell Physiol 178, 121-132.
30. Elvert G, Kappel A, Heidenreich R, Englmeier U, Lanz S, Acker T, Rauter M, Plate K, Sieweke M, Breier G, Flamme I (2003) Cooperative interaction of hypoxia-inducible factor- 2alpha (HIF-2alpha) and Ets-1 in the transcriptional activation of vascular endothelial growth factor receptor-2 (Flk-1). J Biol Chem 278, 7520-7530.
31. Wakiya K, Begue A, Stehelin D, Shibuya M (1996) A cAMP response element and an Ets motif are involved in the transcriptional regulation of flt-1 tyrosine kinase (vascular endothelial growth factor receptor 1) gene. J Biol Chem 271, 30823-30828.
32. Zhan Y, Brown C, Maynard E, Anshelevich A, Ni W, Ho IC, Oettgen P (2005) Ets-1 is a critical regulator of Ang II mediated vascular inflammation and remodeling. J Clin Invest 115, 2508-2516.
33. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease (1997) . The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. Neurobiol Aging 18, S1-2.
34. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BT, National Institute on Aging, Alzheimer, Association (2012) National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: A practical approach. Acta Neuropathol 123, 1-11.
35. Braak H, Braak K (1991) Neuropatholological stageing of Alzheimer-related changes. Acta Neuropathol 82, 239-259.
36. Tarkowski E, Issa R, Sjogren M, Wallin A, Blennow K, Tarkowski A, Kumar P (2002) Increased intrathecal levels of the angiogenic factors VEGF and TGF-beta in Alzheimer's disease and vascular dementia. Neurobiol Aging 23, 237-243.
37. Smith EE, Greenberg SM(2009) Beta-amyloid, blood vessels, and brain function. Stroke 40, 2601-2606.
38. Herzig MC, Van Nostrand WE, Jucker M (2006) Mechanism of cerebral beta-amyloid angiopathy: Murine and cellular models. Brain Pathol 16, 40-54.
39. Meyer EP, Ulmann-Schuler A, Staufenbiel M, Krucker T (2008) Altered morphology and 3D architecture of brain vasculature in a mouse model for Alzheimer's disease. Proc Natl Acad Sci U S A 105, 3587-3592.
40. Zlokovic BV (2010) Neurodegeneration and the neurovascular unit. Nat Med 16, 1370-1371.